Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.
- Status
- ENROLLING_BY_INVITATION
- Phase
- NA
Clinical Trials Related to Neuroblastoma
Related studies linked through entity extraction aliases.
Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or Neuroblastoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Serial ctDNA and Molecular Residual Disease Monitoring in Neuroblastoma
- Status
- RECRUITING
- Phase
- N/A
An Imaging Study of Anti-GD2-800CW in Patients With Neuroblastoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
B7-H3.CD28Z.CART in Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + Dinutuximab
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Fecal Microbiota Transplant for Neuroblastoma in a Single Patient
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Paraganglioma
- Status
- RECRUITING
- Phase
- N/A
Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)
- Status
- RECRUITING
- Phase
- PHASE1
Fertility Preservation in Children With Solid Tumors: Detection of Residual Disease by a Sensitive Method
- Status
- RECRUITING
- Phase
- N/A
Comparison of 18F Labeled Analog of MIBG (18F-MFBG) PET/CT and 123I-MIBG SPECT in Pediatric Patients With Neuroblastoma.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
GSL Synthetase Inhibitor Plus GM-CSF and/ or Immune Checkpoint Inhibitor in Previously Treated High-Risk Neuroblastoma.
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Safety & Efficacy of IR-101 in Relapsed/Refractory Neuroblastoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
- Status
- RECRUITING
- Phase
- PHASE1
Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma
- Status
- RECRUITING
- Phase
- PHASE1
DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Clinical Trial on Autologous NK Cells Combined With GD2 Monoclonal Antibody in the Treatment of Children With Newly Diagnosed High-risk or Relapsed/Refractory Neuroblastoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Arsenic Trioxide With MAPK Inhibitors and Chemotherapy for Stage 4/M Neuroblastoma
- Status
- RECRUITING
- Phase
- PHASE2